Human Reproduction, Vol. 8, No. 7, pp. 1015-1020, 1993
© 1993 European Society of Human Reproduction and Embryology
other |
CLINICAL REPORT: The use of intravenous albumin in patients at high risk for severe ovarian hyperstimulation syndrome
The University of California-Irvine, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility 101 The City Drive, Bldg. 40, Orange, CA 92668, USA
Correspondence: 1To whom correspondence should be addressed
Previous experiences in subjects with other forms of third space fluid accumulation have shown that albumin is efficacious in preventing and correcting haemodynamic instability. Using a similar approach in an effort to increase the serum oncotic pressure and to reverse the leakage of fluids from the intravascular space, high risk subjects for severe ovarian hyperstimulation syndrome (SOHS) were treated with albumin. In a recent large study two high risk factors were identified, i.e. the number of oocytes and levels of serum oestradiol. Thirty-six women undergoing assisted reproductive techniques who presented both these factors, received intravenous albumin at a dose of 5% in Ringers lactate in doses of 500 ml during oocyte retrieval and 500 ml immediately thereafter in the recovery room. Daily measurements of urine output, serum and urine electrolytes, weight, abdominal girth, and haematocrit prior to and after oocyte retrieval revealed normal serum and urine electrolyte levels, and no signs of haemoconcentration. No patient in this study developed SOHS, and of course none had to be hospitalized. Vaginal ultrasound performed in the majority of the subjects revealed 
100 ml of peritoneal fluid 48–72 h after oocyte retrieval. The only complication from the use of intravenous albumin was the appearance of a ‘flu-like condition’ (low grade temperature, nausea and muscle pains) developed by 12 women between days 3 and 5 after oocyte collection. Intravenous albumin had thus prevented the development of severe ovarian hyperstimulation syndrome in an assisted reproduction programme. Its use could allow the maintenance of treatment in patients that otherwise would have been cancelled due to their high risk of developing this condition. The proposed mechanisms of action include increase in plasma oncotic pressure, and in the sex steroid binding capacity of the plasma. Both factors could prevent leakage of fluid from the intravascular space into the peritoneal cavity.
Key words: high risk subjects/human albumin/ovarian hyperstimulation
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A.J. Tozer, R.K. Iles, E. Iammarrone, R.A. Nica, C.M.Y. Gillott, W. XuSong, T. Al-Shawaf, and J.G. Grudzinskas Characteristics of populations of granulosa cells from individual follicles in women undergoing 'coasting' during controlled ovarian stimulation (COS) for IVF Hum. Reprod., November 1, 2004; 19(11): 2561 - 2568. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bellver, E. A. Munoz, A. Ballesteros, S. R. Soares, E. Bosch, C. Simon, A. Pellicer, and J. Remohi Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: a randomized controlled study Hum. Reprod., November 1, 2003; 18(11): 2283 - 2288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Bellver, E. Escudero, and A. Pellicer Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome (OHSS): Ovarian mutilating surgery is not an option in the management of severe OHSS Hum. Reprod., July 1, 2003; 18(7): 1363 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aboulghar Prediction of ovarian hyperstimulation syndrome (OHSS): Estradiol level has an important role in the prediction of OHSS Hum. Reprod., June 1, 2003; 18(6): 1140 - 1141. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Levinsohn-Tavor, S. Friedler, M. Schachter, A. Raziel, D. Strassburger, and R. Ron-El Coasting--what is the best formula? Hum. Reprod., May 1, 2003; 18(5): 937 - 940. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z.O. Amarin Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome: An aggressive, but perhaps life-saving procedure Hum. Reprod., April 1, 2003; 18(4): 659 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aboulghar, J.H. Evers, and H. Al-Inany Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review Hum. Reprod., December 1, 2002; 17(12): 3027 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Delvigne and S. Rozenberg Preventive attitude of physicians to avoid OHSS in IVF patients Hum. Reprod., December 1, 2001; 16(12): 2491 - 2495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ben-Chetrit, T. Eldar-Geva, M. Gal, M. Huerta, T. Mimon, N. Algur, Y. Z. Diamant, and E. J. Margalioth The questionable use of albumin for the prevention of ovarian hyperstimulation syndrome in an IVF programme: a randomized placebo-controlled trial Hum. Reprod., September 1, 2001; 16(9): 1880 - 1884. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Al-Shawaf, A. Zosmer, S. Hussain, A. Tozer, N. Panay, C. Wilson, A.M. Lower, and J.G. Grudzinskas Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified `coasting' strategy based on ultrasound for identification of high-risk patients Hum. Reprod., January 1, 2001; 16(1): 24 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Khalaf, N. Elkington, H. Anderson, A. Taylor, and P. Braude Ovarian hyperstimulation syndrome and its effect on renal function in a renal transplant patient undergoing IVF treatment: Case report Hum. Reprod., June 1, 2000; 15(6): 1275 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Graf and R. Fischer Severe OHSS: An `epidemic' of severe OHSS: a price we have to pay? Hum. Reprod., December 1, 1999; 14(12): 2930 - 2931. [Full Text] [PDF]
|
|
|
|
|
|
R.G. Forman Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. Hum. Reprod., November 1, 1999; 14(11): 2681 - 2686. [Full Text] [PDF]
|
|
|
|
|
|
R.G. Forman Severe OHSS--an acceptable price? Hum. Reprod., November 1, 1999; 14(11): 2687 - 2688. [Full Text] [PDF]
|
|
|
|
|
|
M. Al-Ramahi Severe OHSS: Decreasing the risk of severe ovarian hyperstimulation syndrome Hum. Reprod., October 1, 1999; 14(10): 2421 - 2422. [Full Text] [PDF]
|
|
|
|
|
|
T. Koike, S. Araki, S. Ogawa, H. Minakami, and I. Sato Does i.v. albumin prevent ovarian hyperstimulation syndrome? Hum. Reprod., July 1, 1999; 14(7): 1920 - 1920. [Full Text] [PDF]
|
|
|
|
|
|
P.E. Egbase, M. A. Sharhan, and J.G. Grudzinskas Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study Hum. Reprod., June 1, 1999; 14(6): 1421 - 1425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.P. Ferraretti, L. Gianaroli, C. Magli, D. Fortini, H.A. Selman, and E. Feliciani Elective cryopreservation of all pronucleate embryos in women at risk of ovarian hyperstimulation syndrome: efficiency and safety Hum. Reprod., June 1, 1999; 14(6): 1457 - 1460. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Doldi, A. Destefani, A. Gessi, D. Grossi, and A. Ferrari Human albumin enhances expression of vascular endothelial growth factor in cultured human luteinizing granulosa cells: importance in ovarian hyperstimulation syndrome Hum. Reprod., May 1, 1999; 14(5): 1157 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Waldenstrom, J. Kahn, L. Marsk, and S. Nilsson High pregnancy rates and successful prevention of severe ovarian hyperstimulation syndrome by `prolonged coasting' of very hyperstimulated patients: a multicentre study Hum. Reprod., February 1, 1999; 14(2): 294 - 297. [Abstract] [Full Text] [PDF]
|
|